Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer
Clinical trial NCT06856187 · RECRUITING
Trial details
- NCT number
- NCT06856187
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-06-30
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.